IMCGX Performance — Transamerica Mid Cap Growth, Class I
Data updated: 2026-09-28
IMCGX returned +6.25% year to date and +1.11% over one year to Jul 2026. Annualised returns are +11.86% over 3 years and +3.19% over 5 years. Against its US Mid-Cap Growth category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $140, against $139 for the category, and to $101 over one year, against $110. Volatility over the past three years was 19.43% a year. In the 12 months to Jul 2026 the fund took in a net $2.6M, and assets reached $133.67M.
IMCGX Growth of $100
What $100 invested in Transamerica Mid Cap Growth grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | IMCGX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $101 | $110 |
| 3 years (Aug 2023 – Jul 2026) | $140 | $139 |
| 5 years (Aug 2021 – Jul 2026) | $117 | $121 |
| Since data start (Aug 2019 – Jul 2026) | $182 | $189 |
IMCGX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.25% |
| 1 year | +1.11% |
| 3 years (annualised) | +11.86% |
| 5 years (annualised) | +3.19% |
IMCGX Annual Returns
Calendar-year total returns of Transamerica Mid Cap Growth, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +6.25% |
| 2025 | +7.51% |
| 2024 | +16.51% |
| 2023 | +31.86% |
| 2022 | −31.83% |
| 2021 | +6.59% |
| 2020 | +30.33% |
| 2019 (Aug–Dec) | +9.64% |
IMCGX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.7% | +2.4% | −5.9% | +8.0% | +6.9% | +2.9% | −5.5% | — | — | — | — | — |
| 2025 | +7.2% | −6.7% | −8.4% | +4.1% | +10.3% | +6.6% | +0.8% | −1.1% | +0.3% | −1.3% | −2.0% | −0.7% |
| 2024 | −1.3% | +8.2% | +2.9% | −6.8% | −1.6% | +1.1% | +2.1% | +5.7% | +1.9% | −1.4% | +10.4% | −4.5% |
| 2023 | +11.2% | −1.1% | +2.0% | −2.9% | +2.2% | +8.7% | +3.5% | −1.4% | −5.7% | −7.2% | +12.3% | +8.6% |
| 2022 | −13.6% | −1.2% | +1.9% | −13.4% | −4.0% | −8.3% | +11.7% | −3.2% | −9.2% | +6.9% | +5.1% | −6.6% |
| 2021 | −1.0% | +3.8% | −1.9% | +5.3% | −4.0% | +5.4% | +1.7% | +2.4% | −3.7% | +6.2% | −8.9% | +2.6% |
| 2020 | +0.9% | −8.1% | −15.1% | +15.4% | +10.9% | +3.6% | +5.4% | +3.6% | −2.1% | −0.3% | +12.3% | +4.2% |
| 2019 | — | — | — | — | — | — | — | −1.1% | +1.2% | +3.7% | +4.2% | +1.4% |
IMCGX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 19.43%
- 3-year Sharpe ratio: 0.38 (vs 4.5% risk-free rate)
- Best month: +12.28% (Nov 2023)
- Worst month: −8.39% (Mar 2025)
IMCGX Fund Flows
Monthly money in and out of Transamerica Mid Cap Growth, from SEC Form N-PORT.
- 12-month net flow: $2.6M
- 12-month gross sales (incl. reinvestments): $35.3M
- Sales ÷ redemptions: 1.08×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $761K | $2.1M | −$1.4M |
| Jun 2026 | $569K | $698K | −$129K |
| May 2026 | $390K | $1.1M | −$739K |
| Apr 2026 | $517K | $3.0M | −$2.5M |
| Mar 2026 | $350K | $2.8M | −$2.5M |
| Feb 2026 | $798K | $4.5M | −$3.7M |
| Jan 2026 | $467K | $1.3M | −$859K |
| Dec 2025 | $28.1M | $1.4M | $26.7M |
| Nov 2025 | $408K | $2.2M | −$1.8M |
| Oct 2025 | $272K | $3.5M | −$3.2M |
| Sep 2025 | $1.3M | $1.7M | −$465K |
| Aug 2025 | $1.4M | $8.3M | −$6.9M |
IMCGX Assets Under Management
Net assets of Transamerica Mid Cap Growth by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $133.67M |
| 2026-04-30 | $130.73M |
| 2026-01-31 | $134.44M |
| 2025-10-31 | $144.04M |
| 2025-07-31 | $157.99M |
| 2025-04-30 | $129.08M |
| 2025-01-31 | $154.49M |
| 2024-10-31 | $145.86M |
| 2024-07-31 | $139.81M |
| 2024-04-30 | $227.00M |
| 2024-01-31 | $416.28M |
| 2023-10-31 | $357.54M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.